International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Biomed Rep 11:[Related article:] 191-198, 2019; DOI: 10.3892/br.2019.1242
Subsequently to the publication of the above article, the authors have noted that the Abstract and the Acknowledgements contained errors and an omission, respectively, and wish to correct these points for the record. First, in the Abstract, on p. 191, the pair of consecutive sentences beginning on line 16 should have read as follows (changes highlighted in bold and in the subsequent parentheses): “In the non-fatty liver group, the odds ratio (OR) for hypertension was 1.73 (1.04-2.88; P=0.035). In the fatty liver group, the OR for each Mets-related diseases were as follows: Dyslipidemia, 0.64 (0.44-0.95; P=0.028); impaired glucose tolerance, 0.57 (0.37-0.88; P=0.012); chronic kidney disease, 0.58 (0.36-0.94; P=0.029); and Mets by Japanese criteria, 0.63 (0.44-0.92; P=0.016). (“2”, featured erroneously after “1.04-2.88”, has been omitted). Secondly, in the Acknowledgements section, “Noriko” should have been properly acknowledged as follows: “The authors thank all the members of the Department of Gastroenterology and Hepatology, Fukuchiyama City Hospital. The authors would also like to thank Ms. Noriko Nishikawa, of the medical division staff, for assistance with data collection.”
The authors apologize for these errors, and for any inconvenience caused.